Drug Delivery

Partnership speeds the development of pressurised metered dose inhalers

Honeywell has partnered with CDMO Recipharm on a commercial partnership that will speed the development of pressurised metered dose inhalers

Breaking News

PackGene partners Kudo Bio on customised mRNA manufacturing

The two companies have partnered to develop end-to-end coverage of mRNA development, from gene to mRNA, lipid nanoparticle (LNP) formulation develo...

Intravaac shares publication of OMV-based intranasal vaccine review

The CDMO has shared the publication in Current Opinion in Immunology regarding the efficacy its OMV-based vaccines, administered intranasally

Mitsubishi signs agreement with Roquette for Qualicaps shares

Pharmaceutical excipients expert Roquette has signed an agreement with the MCG Group for the shares of hard capsule manufacturer Qualicaps

Taking a decentralised approach to commercialising cell and gene therapies

With the medical world facing some of the worst cancer drug shortages in history, many thousands of patients are not getting the treatments they ne...

Partnership speeds the development of pressurised metered dose inhalers

Honeywell has partnered with CDMO Recipharm on a commercial partnership that will speed the development of pressurised metered dose inhalers

BDD secures further round of investment for drug delivery tech

The company has secured a further round of investment for £2 million (USD $2.5 million) to aid its expansion in response to growing demand for drug...

What's in an FDA approval? How a start-up company gets its drug to market

The FDA wields a supreme amount of power in the regulatory realm of the pharmaceutical industry. For smaller start-ups or those newer to the indust...

Catalent signs development deal with Ethicann for new fast-dissolve cannabinoid treatment

Catalent and Canadian/US cannabinoid drug therapy company Ethicann Pharmaceuticals have executed a development and license agreement that will use...

NIH selects Exothera for manufacturing of Covid intranasal vaccine

The CDMO Exothera has been selected by the National Institutes of Health to develop the manufacturing process for its intranasal vaccine against SA...

TAE Life Sciences to distribute drug for boron neutron capture therapy

Biddle Sawyer have agreed with TAE Life Sciences to be the supplier of a novel boronated amino acid analog drug for boron neutron capture therapy

Establishing a rigorous and robust approach to topical drug product process development: part II

The aim of process development is to establish optimal process parameters and conditions for future large-scale batches or commercialisation, ensur...

Inspiration from unexpected places

How pharmaceutical companies can learn from advances in nicotine delivery

Spexis secures funding for cystic fibrosis infection treatment

The company has confirmed funding of USD $2.5m to go towards upcoming Phase 3 studies for ColiFin, an inhaled therapeutic to counter chronic infect...

Establishing a rigorous and robust approach to topical drug product process development: part I

The aim of process development is to establish optimal process parameters and conditions for future large-scale batches or commercialisation, ensur...

Full details from Calliditas Therapeutics’ Phase 3 study released

Calliditas Therapeutics has announced publication in The Lancet of the full data from the Phase 3 NefIgArd Study with Nefecon delayed release capsu...

Adding a new chapter to the history of capsule-based drug delivery

For more than 100 years, capsules have consisted of two pieces (a body and a cap). Nutritional or pharmaceutical ingredients are dosed into the bod...